ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,510,490 | +12.2% | 1,001,000 | +8.8% | 1.52% | +7.3% |
| Q2 2023 | $18,280,400 | +16.0% | 920,000 | 0.0% | 1.41% | +35.9% |
| Q1 2023 | $15,759,600 | -5.3% | 920,000 | +8.2% | 1.04% | +0.1% |
| Q4 2022 | $16,634,500 | +64.7% | 850,000 | +34.3% | 1.04% | +115.6% |
| Q3 2022 | $10,100,000 | +16.0% | 632,822 | 0.0% | 0.48% | +12.4% |
| Q2 2022 | $8,708,000 | -10.4% | 632,822 | +3.3% | 0.43% | -16.4% |
| Q1 2022 | $9,719,000 | -27.4% | 612,822 | 0.0% | 0.51% | -19.0% |
| Q4 2021 | $13,378,000 | -16.2% | 612,822 | +14.7% | 0.63% | -23.4% |
| Q3 2021 | $15,964,000 | – | 534,085 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |